Nearly eight months after taking charge of King of Prussia-based Vertex Inc., CEO Christopher Young is applying lessons from ...

Vertex Pharmaceuticals (VRTX) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to ...

Vertex AI is a comprehensive machine learning platform by Google Cloud, provides an all-inclusive suite of tools and resources for the creation, deployment, and customization of machine learning ...

Arcutis doubled revenue last year while Vertex delivered strong profits and cash flow. Explore how each company stacks up on ...

Dyne pursues rare disease breakthroughs while Vertex leverages blockbuster profits for pipeline expansion, how do their risk ...

Sundar Pichai introduced Vertex AI to the world during the Google I/O 2021 conference last year, placing it against managed AI platforms such as Amazon Web Services (AWS) and Azure in the global AI ...

One firm sees room for this tech stock to run.

Vertex Pharmaceuticals (NDAQ: VRTX) stands today as a top 20 pharma company with over a $100 billion market cap. But this biotech beacon has ridden a bumpy path to its current perch and, along the way ...

Vertex Pharmaceuticals (NASDAQ: VRTX) has been a top pharma stock in recent years. It has been generating strong revenue growth while also building out its portfolio of drugs, expanding its growth ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...